After discussing a topic with facebook friends and activists I learned that there is a growing desire to reschedule cannabis in Washington state. I posted my opposition to this yesterday, because after having this idea myself in 2009 and collecting signatures on a petition to do just that, I have learned a lot of things about this process that has made me change my mind.
Now the CDC, Cannacare and other medical marijuana groups in WA are proposing rescheduling.
I thought it was entirely peculiar that so many people were talking about this all at once.
Well, read it and weap, cannabis is about to be changed forever as we’ve known it:
http://cdc.coop/docs/2011_rescheduling_petition.pdf
http://xcannabis.com//uploads/2011/05/2011_rescheduling_petition.pdf
Here are my thoughts and at the bottom I will give you some research to consider:
- Rescheduling cannabis rather than removing it from the list, will NOT prevent MOST cannabis consumers from going to jail.
- Rescheduling cannabis in Washington will not over ride federal supremacy clause via Article VI, etc.
http://en.wikipedia.org/wiki/Supremacy_Clause - This will open more doors to BIG pharma (not the little guys) for getting into the cannabis business, and leaving the rest of us out.
- Once big pharma is involved and once they put their money into cannabis, prohibition will not decrease, they will fight harder to keep it a schedule II, because it benefits them more.
- The US government already has dozens of patents on cannabis, and when it is rescheduled those patents will be more effective for them. Meaning they will further OWN cannabis as opposed to now. As a schedule I, those patents can’t really be utilized. Under schedule II they can give their big pharma friends and contributors the rights to utilize those patents
- I have known about the patent for neuroprotection and anti-oxidants for years now.
US Patent 6630507 - There are also many OTHER patents on cannabis:
- 2304669 1942 Isolation of cannabidiol - 20110217.005017
- 2354492 1944 Marihuana active compound - 20110217.005419
- 2419934 1947 Optically active tetrahydrodibenzopyrans having marihuana activity and process for .. - 20110217.010128
- 2419935 1947 Marihuana active compounds - 20110217.010934
- 2419936 1947 Preparation of compounds with marihuana activity - 20110217.011517
- 2509386 1950 Dibenzopyran marihuana-like compounds - 20110217.012129
- 2509387 1950 Dibenzopyran marihuana-like compounds - 20110217.012513
- 3668224 1972 Process of producing 6a, 10a-trans-6a,7,8,10a-tetrahydrodibenzo (b,d)-pyrans - 20110217.013244
- 3728360 1973 Ester derivatives of tetrahydrocannabinol - 20110217.013646
- 3734930 1973 Direct synthesis of (-)-trans-delta-9-tetrahydrocannabinol from olivetol and (+)-tr.. - 20110217.005434
- 4025516 1977 Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-p.. - 20110217.022419
- 4116979 1978 Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-p.. - 20110217.030800
- 4126694 1978 Composition and method for treating glaucoma - 20110217.031302
- 4126695 1978 Anti-glaucoma composition and method - 20110217.031624
- 4179517 1979 Novel tetrahydrocannabinol type compounds - 20110217.032121
- 4189491 1980 Tetrahydrocannabinol in a method of treating glaucoma - 20110217.032351
- 4195078 1980 Nabilone granulation - 20110219.131638
- 4279824 1981 Method and apparatus for processing herbaceous plant materials including the plant .. - 20110221.005824
- 4315862 1982 Process for preparing cannabichromene - 20110219.132528
- 4327028 1982 Composition of matter - 20110219.132854
- 4464378 1984 Method of administering narcotic antagonists and analgesics - 20110219.134318
- 4476140 1984 Composition and method for treatment of glaucoma - 20110219.133925
- 4758597 1988 Carenadiol and derivatives - 20110220.235422
- 4837228 1989 Antiinflammatory and antimicrobial compounds and compositions - 20110219.135422
- 4847290 1989 Delta 1-thc-7-oic acid and analgesic and anti-inflammatory agents - 20110219.140914
- 4876276 1989 (3s-4s)-7-hydroxy-delta-6-tetrahydrocannabinols - 20110219.141600
- 4933363 1990 Method for effecting systemic delivery of delta-9-tetrahydrocannabinol - 20110219.144031
- 5227537 1993 Method for the production of 6,12-dihydro-6-hydroxy-cannabidiol and the use thereof.. - 20110221.005135
- 5237057 1993 Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol d.. - 20110219.144538
- 5292899 1994 Synthesis of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid glucuronide - 20110219.145249
- 5302703 1994 Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol d.. - 20110219.145809
- 5338753 1994 (3r,4r)-delta-6-tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents .. - 20110219.150617
- 5342971 1994 Process for the preparation of dibenzo[b,d]pyrans - 20110219.150655
- 5389375 1995 Stable suppository formulations effecting bioavailability of delta-9-thc - 20110219.151015
- 5440052 1995 Compositions useful as a cannabinoid receptor probe - 20110219.151453
- 5508037 1996 Stable suppository formulations effecting bioavailability of delta-9-thc - 20110219.151931
- 5532237 1996 Indole derivatives with affinity for the cannabinoid receptor - 20110219.152606
- 5538993 1996 Certain tetrahydrocannabinol-7-oic acid derivatives - 20110219.152901
- 5596106 1997 Cannabinoid receptor antagonists - 20110219.153207
- 5605906 1997 Cannabinoid receptor agonists - 20110219.153325
- 5605928 1997 Antiemetic compositions - 20110219.153523
- 5631297 1997 Anandamides useful for the treatment of intraocular hypertension… - 20110219.160906
- 5635530 1997 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processor.. - 20110219.154139
- 5688825 1997 Anandamide amidase inhibitors as analgesic agents - 20110219.161202
- 5716638 1998 Composition for applying active substances to or through the skin - 20110219.161548
- 5747524 1998 Cannabinoid receptor antagonists - 20110219.161846
- 5804592 1998 Method for improving disturbed behavior and elevating mood in humans - 20110219.162419
- 5847128 1998 Water soluble derivatives of cannabinoids - 20110219.162859
- 5872148 1999 Compositions useful as a cannabinoid receptor probe - 20110219.163222
- 5874459 1999 Anandamide amidase inhibitors as analgesic agents - 20110219.163805
- 5925768 1999 pyrazolecarboxamide derivatives having cannabinoid receptor affinity - 20110219.164326
- 5932610 1999 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals - 20110219.164744
- 5939429 1999 Cardiovascular uses of cannabinoid compounds - 20110219.164958
- 5948777 1999 Cannabinoid receptor agonists - 20110219.165232
- 5977180 1999 Anandamide analog compositions and method of treating intraocular hypertension usin.. - 20110219.165507
- 5990170 1999 Therapeutic use of mono and bicarboxylic acid amides active at the peripheral canna.. - 20110219.165901
- 6008383 1999 Method of preparing delta-9-tetrahydrocannabinol esters - 20110219.170127
- 6013648 2000 Cb2 receptor agonist compounds - 20110219.170359
- 6017919 2000 Compounds and pharmaceutical use thereof - 20110219.232239
- 6096740 2000 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions - 20110219.232844
- 6100259 2000 Cannabinoid receptor modulators - 20110219.233213
- 6113940 2000 Cannabinoid patch and method for cannabis transdermal delivery - 20110219.233850
- 6132762 2000 Transcutaneous application of marijuana - 20110219.234036
- 6162829 2000 (3r,4r)-delta-8-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents.. - 20110219.234311
- 6166066 2000 Cannabinoids selective for the cb2 receptor - 20110219.234631
- 6274635 2001 Alkylated resorcinol derivatives for the treatment of immune diseases - 20110219.235354
- 6284788 2001 Use of known agonists of the central cannabinoid receptor cb1 - 20110219.235654
- 6328992 2001 Cannabinoid patch and method for cannabis transdermal delivery - 20110220.000814
- 6331560 2001 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals - 20110220.002503
- 6344474 2002 Use of central cannabinoid receptor antagonists for regulating appetence - 20110220.002717
- 6355650 2002 (3r,4r)-delta-8-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents.. - 20110220.002953
- 6380175 2002 Method for enhancement of delivery of thc by the administration of its prodrugs via.. - 20110220.003309
- 6383513 2002 Compositions comprising cannabinoids - 20110220.003536
- 6391909 2002 Anandamide inhibitors as analgesic agents - 20110220.003752
- 6448288 2002 Cannabinoid drugs - 20110220.004111
- 6509005 2003 delta-9 tetrahydrocannabinol (delta-9 thc) solution metered dose inhaler - 20110220.010440
- 6509367 2003 Pyrazole cannabinoid agonist and antagonists - 20110220.010824
- 6545041 2003 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals - 20110220.011159
- 6563009 2003 Vasodilator cannabinoid analogs - 20110220.011723
- 6566560 2003 Resorcinolic compounds - 20110220.012340
- 6579900 2003 Anandamide amidase inhibitors as analgesic agents - 20110220.013014
- 6610737 2003 Non psychotropic cannabinoids - 20110220.013607
- 6630507 2003 Cannabinoids as antioxidants and neuroprotectants - 20110217.040403
- 6642258 2003 Use of central cannabinoid receptor antagonist for preparing medicines-20110220.141047
- 6653304 2003 Cannabinoid receptor modulators, their processes of preparation, and use of cannabi.. - 20110220.141700
- 6703418 2004 Appetite stimulation and induction of weight gain in patients suffering from sympto.. - 20110220.141926
- 6713048 2004 Delta-9 tetrahydrocannabinol (delta-9 thc) solution metered dose inhalers and metho.. - 20110220.142152
- 6747058 2004 Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol a.. - 20110220.142350
- 6825209 2004 Compounds having unique cb1 receptor binding selectivity and methods for their prod.. - 20110220.142627
- 6864291 2005 Agonists specific for the peripheral cannabinoid receptor - 20110220.142827
- 6900236 2005 Cannabimimetic indole derivatives - 20110220.143112
- 6903137 2005 Agonists specific for the peripheral cannabinoid receptor - 20110220.144738
- 6930122 2005 Use of central cannabinoid receptor antagonist for preparing medicines designed to .. - 20110220.225951
- 6939977 2005 Analgesic and immunomodulatory cannabinoids - 20110220.230157
- 6943266 2005 Bicyclic cannabinoid agonists for the cannabinoid receptor - 20110220.230355
- 6949582 2005 Method of relieving analgesia and reducing inflamation using a cannabinoid delivery.. - 20110220.230551
- 6974568 2005 Treatment for cough - 20110220.231124
- 6995187 2006 Peripheral cannabinoid receptor (cb2) selective ligands - 20110220.231316
- 7049329 2006 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof - 20110220.231649
- 7057076 2006 Bicyclic and tricyclic cannabinoids - 20110220.231942
- 7067539 2006 Cannabinoid receptor ligands - 20110220.232124
- 7071213 2006 Cannabinoid receptor ligands - 20110220.232329
- 7088914 2006 Device, method and resistive element for vaporizing a medicament - 20110220.232627
- 7105685 2006 Cannabinol derivatives - 20110220.232801
- 7109245 2006 Vasoconstrictor cannabinoid analogs - 20110220.233007
- 7119108 2006 Pyrazole derivatives as cannabinoid receptor antagonists - 20110220.233254
- 7129239 2006 Purine compounds and uses thereof - 20110220.233510
- 7141669 2006 Cannabiniod receptor ligands and uses thereof - 20110220.233811
- 7145012 2006 Cannabinoid receptor ligands and uses thereof - 20110220.234023
- 7161016 2007 Cannabimimetic lipid amides as useful medications - 20110220.234200
- 7169942 2007 Cannabinoid derivatives, methods of making, and use thereof - 20110220.234343
- 7173027 2007 Receptor selective cannabimimetic aminoalkylindoles - 20110220.234621
- 7176210 2007 Cannabinoid receptor ligands and uses thereof - 20110220.234841
- 7179800 2007 Cannabinoids - 20110220.235606
- 7183313 2007 Keto cannabinoids with therapeutic indications - 20110220.235821
- 7217732 2007 Cannabinoid receptor agonists - 20110221.000020
- 7220743 2007 Heterocyclic cb1 receptor antagonists - 20110221.000208
- 7229999 2007 Pyridine-3-carboxamide derivatives as cb1 inverse agonists - 20110221.000408
- 7232823 2007 Cannabinoid receptor ligands and uses thereof - 20110221.000602
- 7235584 2007 Non psychotropic cannabinoids - 20110221.000739
- 7241799 2007 Cannabimimetic indole derivatives - 20110221.000920
- 7247628 2007 Cannabinoid receptor ligands and uses thereof - 20110221.001058
- 7268133 2007 Cannabinoid receptor ligands and uses thereof - 20110221.001308
- 7276516 2007 Cb1 antagonist compounds - 20110221.002759
- 7276613 2007 Retro-anandamides, high affinity and stability cannabinoid receptor ligands - 20110221.002935
- 7285683 2007 Bicyclic and tricyclic cannabinoids - 20110221.003404
- 7285687 2007 Cannabinoids - 20110221.003830
- 7294644 2007 Cb 1 receptor inverse agonists - 20110221.004028
- 7321047 2008 Separation of tetrahydrocannabinols - 20110221.004243
- 7323576 2008 Synthetic route to dronabinol - 20110221.004441
- 7329651 2008 Cannabimimetic ligands - 20110221.004633
- 7329658 2008 Cannabinoid receptor ligands and uses thereof - 20110221.004825
- 7335688 2008 Bicyclic cannabinoid agonists for the cannabinoid receptor - 20110221.005006
- 7344736 2008 Extraction of pharmaceutically active components from plant materials - 20110221.005455
- 7354929 2008 Cannabinoid receptor ligands and uses thereof - 20110221.010029
- 7358245 2008 Treatment of gastroesophageal reflux disease - 20110221.010322
- 7393842 2008 Pyrazole analogs acting on cannabinoid receptors - 20110221.010732
- 7399872 2008 Conversion of cbd to delta-8-thc and delta-9-thc - 20110221.011142
- 7402686 2008 Cannabinoid crystalline derivatives and process of cannabinoid purification - 20110221.011644
- 7592328 2009 Natural cyclodextrin complexes - 20110221.011900
- 7592468 2009 Production of delta-9 tetrahydrocannabinol - 20110221.012444
- 7648696 2010 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous.. - 20110221.012955
If you are a supporter of these groups, please write them and explain to them how Big Pharma taking over cannabis is NOT what is good for the cannabis community!
Credit for the image at this website:
http://morallowground.com/2011/04/20/big-pharma-set-to-take-over-medical-marijuana-market/
Related Posts
Good news about full legalization of cannabis in the USA June 2011
What are the facts about the controlled substances act?
The THIRD Medical Marijuana Bill in Washington State
Ending the Controlled Substances Act vs. Rescheduling Cannabis
Knowing your “advocates” in Washington
How do we end the controlled substances act for ALL states?
Monopolies and the cannabis market
- Ian Moody for US Congress? I am concerned about his plan.


